Process for coupling antibodies or antibody fragments to liposomes
AssigneeAbbott Laboratories
InventorsYi-Her Jou, Roger C. Hu, Peter A. Lagocki
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbbott Laboratories
InventorsYi-Her Jou, Roger C. Hu, Peter A. Lagocki
Estimating the term…
The present invention provides for novel homogeneous immunoassay systems involving complement-mediated lysis of marker-encapsulating lipid vesicles (liposomes) for detection of analyte in a fluid sample. These systems do not require the separation of unbound antigens and/or antibody conjugates yet provide highly sensitive procedures for analyte detection. Liposomes containing a marker, are coupled to antibody fragments in a way which confers the liposomes with immunological specificity yet avoids sensitizing the liposomes to complement mediated lysis in the absence of analyte. Antibody sensitized liposomes (the first reagent) are sequentially incubated with an analyte-containing sample, and optionally "dummy" liposomes, which do not contain encapsulated marker, a second antibody (the second reagent), and finally with a complement source such as plasma. Complement is activated by the liposome-antibody-antigen-second antibody complex causing liposome lysis and a concomitant release of marker. Also provided are methods for preparing antibody sensitized liposomes in the presence of a polysaccharide capable of forming a reversible gel and methods for preparing derivatized Fab' antibody fragments for coupling to lipid vesicles.
A method for coupling antibody to thiol-containing lipid vesicles which reduces reducing lipid vesicle aggregation during the antibody lipid vesicle conjugation comprising:
Dependencies are inferred from the claim text.